Quadriga BioSciences Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
2ndary - Private
- Investors
-
2
Quadriga BioSciences General Information
Description
Developer of proprietary targeted cancer therapies designed to offer personalized medicine for cancer treatment. The company develops novel targeted molecules against cancer cells that overexpress certain unique amino acid transporters on their cell surface for the intake of nutrients to support rapid tumor growth and proliferation, enabling professionals to deliver safe and effective treatments for patients with cancer.
Contact Information
Website
www.quadrigabiosciences.comCorporate Office
- 95 Main Street
- Suite 9
- Los Altos, CA 94022
- United States
Corporate Office
- 95 Main Street
- Suite 9
- Los Altos, CA 94022
- United States
Quadriga BioSciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Secondary Transaction - Private | 01-Mar-2026 | Completed | Clinical Trials - Phase 1 | |||
| 8. Grant | 01-Sep-2021 | Completed | Clinical Trials - Phase 1 | |||
| 7. Grant | 01-Sep-2021 | Completed | Clinical Trials - Phase 1 | |||
| 6. Later Stage VC (Series A) | 20-Oct-2017 | Completed | Generating Revenue | |||
| 5. Grant | 01-Jan-2017 | Completed | Generating Revenue | |||
| 4. Seed Round | 05-Feb-2015 | Completed | Startup | |||
| 3. Grant | 01-Jun-2013 | Completed | Startup | |||
| 2. Grant | 01-Jun-2013 | $288K | Completed | Startup | ||
| 1. Debt - General | Completed | Startup |
Quadriga BioSciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Series A-2 | ||||||||
| Series A-1 | 1,741,234 | $0.002000 | $0.17 | $2.14 | $2.14 | 1x | $2.14 | 0% |
| Seed | 901,904 | $0.002000 | $1.4 | $1.4 | 1x | $1.4 | 8.94% |
Quadriga BioSciences Patents
Quadriga BioSciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022206282-A1 | Pharmaceutical compositions of chemotherapeutic agents based on beta-substituted beta-amino acid derivatives | Active | 08-Jan-2021 | ||
| AU-2022206282-A9 | Pharmaceutical compositions of chemotherapeutic agents based on beta-substituted beta-amino acid derivatives | Active | 08-Jan-2021 | ||
| AU-2022206282-B2 | Pharmaceutical compositions of chemotherapeutic agents based on beta-substituted beta-amino acid derivatives | Active | 08-Jan-2021 | ||
| AU-2024264662-A1 | Pharmaceutical compositions of chemotherapeutic agents based on beta-substituted beta-amino acid derivatives | Active | 08-Jan-2021 | ||
| AU-2024264662-B2 | Pharmaceutical compositions of chemotherapeutic agents based on beta-substituted beta-amino acid derivatives | Active | 08-Jan-2021 | C08B37/0015 |
Quadriga BioSciences Signals
Quadriga BioSciences Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institutes of Health | Government | |||
| National Cancer Institute | Government |
Quadriga BioSciences FAQs
-
When was Quadriga BioSciences founded?
Quadriga BioSciences was founded in 2010.
-
Where is Quadriga BioSciences headquartered?
Quadriga BioSciences is headquartered in Los Altos, CA.
-
What is the size of Quadriga BioSciences?
Quadriga BioSciences has 5 total employees.
-
What industry is Quadriga BioSciences in?
Quadriga BioSciences’s primary industry is Biotechnology.
-
Is Quadriga BioSciences a private or public company?
Quadriga BioSciences is a Private company.
-
What is Quadriga BioSciences’s current revenue?
The current revenue for Quadriga BioSciences is .
-
How much funding has Quadriga BioSciences raised over time?
Quadriga BioSciences has raised $9M.
-
Who are Quadriga BioSciences’s investors?
National Institutes of Health and National Cancer Institute have invested in Quadriga BioSciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process